Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5136)
All Articles published online
|
Oct 14, 2010 (publication date) through Jan 10, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zlobec I, Molinari F, Martin V, Mazzucchelli L, Saletti P, Trezzi R, De Dosso S, Vlajnic T, Frattini M, Lugli A. Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients. World J Gastroenterol 2010; 16(38): 4823-4831 [PMID: 20939111 DOI: 10.3748/wjg.v16.i38.4823] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i38/4823.htm |
| Number | Citing Articles |
| 1 |
Bojana Mitrovic, David F Schaeffer, Robert H Riddell, Richard Kirsch. Tumor budding in colorectal carcinoma: time to take notice. Modern Pathology 2012; 25(10): 1315 doi: 10.1038/modpathol.2012.94
|
| 2 |
Shreyanshi Gupta, Saraswathy Sreeram, Amanda Christina Pinto, Pooja Kundapur Suresh, Sridevi Hanaganahalli Basavaiah. Tumor Budding Assessment with Cytokeratin and Its Significance in Laryngeal Squamous Cell Carcinomas. Indian Journal of Otolaryngology and Head & Neck Surgery 2022; 74(4): 494 doi: 10.1007/s12070-021-02981-3
|
| 3 |
Bojana Mitrovic, Kelly Handley, Naziheh Assarzadegan, Hector Li Chang, Heather A.E. Dawson, Andrea Grin, Gordon G.A. Hutchins, Laura Magill, Philip Quirke, Robert H. Riddell, Richard G Gray, Richard Kirsch. Prognostic and Predictive Value of Tumor Budding in Colorectal Cancer. Clinical Colorectal Cancer 2021; 20(3): 256 doi: 10.1016/j.clcc.2021.05.003
|
| 4 |
Rani Kanthan, Jenna-Lynn Senger, Selliah Chandra Kanthan. Molecular Events in Primary and Metastatic Colorectal Carcinoma: A Review. Pathology Research International 2012; 2012: 1 doi: 10.1155/2012/597497
|
| 5 |
Valeria Maffeis, Lorenzo Nicolè, Rocco Cappellesso. RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01255
|
| 6 |
Rondell P. Graham, Robert A. Vierkant, Lori S. Tillmans, Alice H. Wang, Peter W. Laird, Daniel J. Weisenberger, Charles F. Lynch, Amy J. French, Susan L. Slager, Yassaman Raissian, Joaquin J. Garcia, Sarah E. Kerr, Hee Eun Lee, Stephen N. Thibodeau, James R. Cerhan, Paul J. Limburg, Thomas C. Smyrk. Tumor Budding in Colorectal Carcinoma. American Journal of Surgical Pathology 2015; 39(10): 1340 doi: 10.1097/PAS.0000000000000504
|
| 7 |
Ashini H. Shah, Amisha J. Gami, Neetal H. Desai, Jahnavi S. Gandhi, Priti P. Trivedi. Tumor budding as a prognostic indicator in colorectal carcinoma: a retrospective study of primary colorectal carcinoma cases in a tertiary care center. Indian Journal of Surgical Oncology 2022; 13(3): 459 doi: 10.1007/s13193-022-01498-7
|
| 8 |
Manabu Takamatsu, Hiroshi Kawachi, Noriko Yamamoto, Maki Kobayashi, Yuka Toyama, Takashi Maekawa, Akiko Chino, Shoichi Saito, Masashi Ueno, Yutaka Takazawa, Yuichi Ishikawa. Immunohistochemical evaluation of tumor budding for stratifying T1 colorectal cancer: optimal cut-off value and a novel computer-assisted semiautomatic method. Modern Pathology 2019; 32(5): 675 doi: 10.1038/s41379-018-0189-1
|
| 9 |
Kabytto Chen, Geoffrey Collins, Henry Wang, James Wei Tatt Toh. Pathological Features and Prognostication in Colorectal Cancer. Current Oncology 2021; 28(6): 5356 doi: 10.3390/curroncol28060447
|
| 10 |
Annette Arndt, Klaus Kraft, Eva Wardelmann, Konrad Steinestel. Lack of Association between Membrane-Type 1 Matrix Metalloproteinase Expression and Clinically Relevant Molecular or Morphologic Tumor Characteristics at the Leading Edge of Invasive Colorectal Carcinoma. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/185404
|
| 11 |
Pantea Pour Farid, Markus Eckstein, Susanne Merkel, Robert Grützmann, Arndt Hartmann, Volker Bruns, Michaela Benz, Regine Schneider-Stock, Carol I. Geppert. Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes. International Journal of Molecular Sciences 2021; 22(23): 13108 doi: 10.3390/ijms222313108
|
| 12 |
Sejin Jang, Mineui Hong, Mi Kyung Shin, Byung Chun Kim, Hyung-Sik Shin, Eunsil Yu, Seung-Mo Hong, Jihun Kim, Sung-Min Chun, Tae-Im Kim, Kyung-Chan Choi, Young Woong Ko, Jeong Won Kim. KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior. Human Pathology 2017; 65: 21 doi: 10.1016/j.humpath.2017.01.010
|
| 13 |
Gaoyan Yao, Yi Fang, Yangbo Fu, Jinghong Xu, Haojun Song, Hangqin Zhu, Mengli Gu, Xiaoyun Ding. Tumor budding as an indicator for lymph node metastasis and prognosis of early gastric cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(9): 5603 doi: 10.1007/s00432-022-04522-z
|
| 14 |
Soo-Jin Cho, Sanjay Kakar. Tumor Budding in Colorectal Carcinoma: Translating a Morphologic Score Into Clinically Meaningful Results. Archives of Pathology & Laboratory Medicine 2018; 142(8): 952 doi: 10.5858/arpa.2018-0082-RA
|
| 15 |
Viktor H Koelzer, Inti Zlobec, Alessandro Lugli. Tumor budding in the clinical management of colon and rectal cancer. Colorectal Cancer 2014; 3(4): 387 doi: 10.2217/crc.14.21
|
| 16 |
Alexandru Grigore, Mohit Jolly, Dongya Jia, Mary Farach-Carson, Herbert Levine. Tumor Budding: The Name is EMT. Partial EMT.. Journal of Clinical Medicine 2016; 5(5): 51 doi: 10.3390/jcm5050051
|
| 17 |
Han-Na Kim, Soo Yeon Lee, Baek-hui Kim, Chung-Yeul Kim, Aeree Kim, Hayeon Kim. Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system. Virchows Archiv 2021; 478(6): 1071 doi: 10.1007/s00428-020-03012-2
|
| 18 |
Alessandro Lugli, Tatjana Vlajnic, Olivier Giger, Eva Karamitopoulou, Efstratios S. Patsouris, George Peros, Luigi M. Terracciano, Inti Zlobec. Intratumoral budding as a potential parameter of tumor progression in mismatch repair–proficient and mismatch repair–deficient colorectal cancer patients. Human Pathology 2011; 42(12): 1833 doi: 10.1016/j.humpath.2011.02.010
|
| 19 |
Kyra B Berg, David F Schaeffer. Tumor budding as a standardized parameter in gastrointestinal carcinomas: more than just the colon. Modern Pathology 2018; 31(6): 862 doi: 10.1038/s41379-018-0028-4
|
| 20 |
Inti Zlobec, Alessandro Lugli. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget. Oncotarget 2010; 1(7): 651 doi: 10.18632/oncotarget.199
|
| 21 |
Bruno Märkl, Hans M Arnholdt. Prognostic significance of tumor budding in gastrointestinal tumors. Expert Review of Anticancer Therapy 2011; 11(10): 1521 doi: 10.1586/era.11.156
|
| 22 |
Marssoni Deconto Rossoni, José Ederaldo Queiroz Telles, Andrea Maciel de Oliveira Rossoni, Jorge Eduardo Fouto Matias. Risk factors for recurrence of stage I/II (TNM) colorectal adenocarcinoma in patients undergoing surgery with curative intent. Journal of Coloproctology 2013; 33(01): 028 doi: 10.1016/j.jcol.2013.02.002
|
| 23 |
Jung Ho Kim, Jeong Mo Bae, Young Seok Song, Nam-Yun Cho, Hye Seung Lee, Gyeong Hoon Kang. Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma. Oncotarget 2016; 7(12): 13372 doi: 10.18632/oncotarget.5618
|
| 24 |
Yuji Konishi, Futoshi Kawamata, Hiroshi Nishihara, Shigenori Homma, Yasutaka Kato, Masumi Tsuda, Shinji Kohsaka, Takahiro Einama, Cheng Liu, Tadashi Yoshida, Akihisa Nagatsu, Mishie Tanino, Shinya Tanaka, Hideki Kawamura, Toshiya Kamiyama, Akinobu Taketomi. Tumor budding and human chorionic gonadotropin-β expression correlate with unfavorable patient outcome in colorectal carcinoma. Medical Oncology 2018; 35(7) doi: 10.1007/s12032-018-1164-x
|
| 25 |
A. Greystoke, S. A. Mullamitha. How Many Diseases Are Colorectal Cancer?. Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/564741
|
| 26 |
Keita Kai, Shinichi Aishima, Shigehisa Aoki, Yukari Takase, Kazuyoshi Uchihashi, Masanori Masuda, Aki Nishijima‐Matsunobu, Mihoko Yamamoto, Kousuke Ide, Atsushi Nakayama, Makiko Yamasaki, Shuji Toda. Cytokeratin immunohistochemistry improves interobserver variability between unskilled pathologists in the evaluation of tumor budding in T1 colorectal cancer. Pathology International 2016; 66(2): 75 doi: 10.1111/pin.12374
|
| 27 |
Ola Marzouk, John Schofield. Review of Histopathological and Molecular Prognostic Features in Colorectal Cancer. Cancers 2011; 3(2): 2767 doi: 10.3390/cancers3022767
|
| 28 |
Derek J. Erstad, Gerald Tumusiime, James C. Cusack. Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon. Annals of Surgical Oncology 2015; 22(11): 3433 doi: 10.1245/s10434-015-4706-x
|
| 29 |
Anne Trinh, Claudia Lädrach, Heather E. Dawson, Sanne ten Hoorn, Peter J. K. Kuppen, Marlies S. Reimers, Miriam Koopman, Cornelis J. A. Punt, Alessandro Lugli, Louis Vermeulen, Inti Zlobec. Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data. British Journal of Cancer 2018; 119(10): 1244 doi: 10.1038/s41416-018-0230-7
|
| 30 |
Asuman Argon, Özden Öz, Tulu Ayata Kebat. Evaluation and prognostic significance of tumor budding in pancreatic ductal adenocarcinomas. Indian Journal of Pathology and Microbiology 2023; 66(1): 38 doi: 10.4103/ijpm.ijpm_905_21
|
| 31 |
Vincenza Granata, Roberta Fusco, Maria Chiara Brunese, Gerardo Ferrara, Fabiana Tatangelo, Alessandro Ottaiano, Antonio Avallone, Vittorio Miele, Nicola Normanno, Francesco Izzo, Antonella Petrillo. Machine Learning and Radiomics Analysis for Tumor Budding Prediction in Colorectal Liver Metastases Magnetic Resonance Imaging Assessment. Diagnostics 2024; 14(2): 152 doi: 10.3390/diagnostics14020152
|
| 32 |
Massimo Pancione, Andrea Remo, Vittorio Colantuoni. Genetic and Epigenetic Events Generate Multiple Pathways in Colorectal Cancer Progression. Pathology Research International 2012; 2012: 1 doi: 10.1155/2012/509348
|
| 33 |
Mineui Hong, Jeong Won Kim, Mi Kyung Shin, Byung Chun Kim. Poorly Differentiated Clusters in Colorectal Adenocarcinomas Share Biological Similarities with Micropapillary Patterns as well as Tumor Buds. Journal of Korean Medical Science 2017; 32(10): 1595 doi: 10.3346/jkms.2017.32.10.1595
|
| 34 |
Qiao Qu, Di Wu, Zhilong Li, Hongzhuan Yin. Tumor budding and the prognosis of patients with metastatic colorectal cancer: a meta-analysis. International Journal of Colorectal Disease 2023; 38(1) doi: 10.1007/s00384-023-04423-8
|
| 35 |
Giacomo Puppa, Carlo Senore, Kieran Sheahan, Michael Vieth, Alessandro Lugli, Inti Zlobec, Sara Pecori, Lai Mun Wang, Cord Langner, Hiroyuki Mitomi, Takatoshi Nakamura, Masahiko Watanabe, Hideki Ueno, Jacques Chasle, Stephen A Conley, Paulette Herlin, Gregory Y Lauwers, Mauro Risio. Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy. Histopathology 2012; 61(4): 562 doi: 10.1111/j.1365-2559.2012.04270.x
|
| 36 |
Eva Karamitopoulou, Inti Zlobec, Viktor Kölzer, Agathi Kondi-Pafiti, Efstratios S Patsouris, Konstantin Gennatas, Alessandro Lugli. Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer. Modern Pathology 2013; 26(2): 295 doi: 10.1038/modpathol.2012.155
|
| 37 |
Sang-Jeon Lee, Song Yi Choi, Wun-Jae Kim, Meiying Ji, Taek-Gu Lee, Bo-Ra Son, Soon Man Yoon, Rohyun Sung, Eun Jeoung Lee, Sei Jin Youn, Seon Mee Park. Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients. Diagnostic Pathology 2013; 8(1) doi: 10.1186/1746-1596-8-99
|
| 38 |
Nan Xie, Cheng Wang, Xiqiang Liu, Ruyao Li, Jinsong Hou, Xiaohua Chen, Hongzhang Huang. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early‐stage tongue squamous cell carcinoma. Journal of Oral Pathology & Medicine 2015; 44(4): 266 doi: 10.1111/jop.12242
|
| 39 |
Viktor H. Koelzer, Inti Zlobec, Alessandro Lugli. Tumor budding in colorectal cancer—ready for diagnostic practice?. Human Pathology 2016; 47(1): 4 doi: 10.1016/j.humpath.2015.08.007
|
| 40 |
Stephen Olsen, Linda Jin, Ryan C. Fields, Yan Yan, ILKe Nalbantoglu. Tumor budding in intestinal-type gastric adenocarcinoma is associated with nodal metastasis and recurrence. Human Pathology 2017; 68: 26 doi: 10.1016/j.humpath.2017.03.021
|